Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab + CHOP in HIV-Related Non-Hodgkin's Lymphoma
NCT00126243Phase 2Terminated
- Sponsor
- ANRS
- Start
- Jan 1999
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of rituximab in AIDS-related lymphoma, sponsored by ANRS. Primary endpoint: Response rate of lymphoma treated. Started Jan 1999; status: terminated.
02
Drugs
rituximab
03
Conditions
AIDS-related lymphoma
Beyond the preview
Go deeper on NCT00126243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00126243.